Atrioventricular Block in Children
Igor A. Kovalev,
Yuri M. Belozerov,
Dinara I. Sadykova,
Dina R. Sabirova,
Lyudmila V. Yakovleva,
Zulfiya R. Khabibrakhmanova,
Andrey S. Sakerin https://doi.org/10.15690/pf.v15i5.1959
Abstract
Rhythm and conduction disorders of the heart occupy one of the leading places in the structure of cardiovascular pathology in children. Atrioventricular block is the slowing down or loss of impulses from the atria to the ventricles. The team of authors presents clinical guidelines based on the principles of evidence-based medicine, including all stages of diagnosis and treatment of children with atrioventricular block. The use of guidelines in clinical practice will allow to choose the best strategy for the diagnosis and treatment of atrioventricular block for each individual patient.
Supporting agencies: Not specified
About the Authors
Igor A. Kovalev
Veltischev Research and Clinical Institute for Pediatrics of the Pirogov Russian National Research Medical University
Russian Federation
Moscow
Russian Federation
Moscow
Yuri M. Belozerov
Veltischev Research and Clinical Institute for Pediatrics of the Pirogov Russian National Research Medical University
Russian Federation
Moscow
Russian Federation
Moscow
Dinara I. Sadykova
Kazan State Medical University
Russian Federation
Kazan
Russian Federation
Kazan
Dina R. Sabirova
Kazan State Medical University
Russian Federation
Kazan
Russian Federation
Kazan
Lyudmila V. Yakovleva
Bashkir State Medical University
Russian Federation
Ufa
Russian Federation
Ufa
Zulfiya R. Khabibrakhmanova
Kazan State Medical University
Russian Federation
Kazan
Russian Federation
Kazan
Andrey S. Sakerin
Mukhina City Clinical Hospital
Russian Federation
Moscow
Russian Federation
Moscow
References
1. Cardiac arrhythmias: their mechanisms, diagnosis, and management. Ed by WJ Mandel. Vol. 2. Transl. from English. Moscow: Meditsina; 1996. 206 p. (In Russ).
2. Belozerov YuM. Detskaya cardiologiya. Moscow: MEDpress-inform; 2004. 525 p. (In Russ).
3. Egorov DF, Adrianov AV. Diagnostika i lechenie bradikardii u detei. St. Petersburg: Chelovek; 2008. 320 p. (In Russ).
4. Brucato A. Prevention of congenital heart block in children of SSA-positive mothers. Rheumatology. 2008;47 Suppl 3:iii35–37. doi: 10.1093/rheumatology/ken153.
5. Walsh EP, Saul JP, Triedman JK. Cardiac arrhythmias in children and young adults with congenital heart disease. 1st ed. Philadelphia, PA, USA: LWW; 2001. 528 p.
6. Brugada J, Blom N, Sarquella-Brugada G, et al. Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. Europace. 2013;15(9):1337–1382. doi: 10.1093/europace/eut082.
7. Allen HD, Driscoll DJ, Shaddy RE, Feltes TF. Moss & Adams’ heart disease in infants, children, and adolescents: including the fetus and young adult. Vol. 1. 7th ed. Philadelphia, PA, USA: LWW; 2008. 760 p.
8. Park MK. Park’s pediatric cardiology for practitioners. 6th ed. Philadelphia, PA: Mosby Elsevier; 2014. 688 p.
9. European Society of Cardiology (ESC); European Heart Rhythm Association (EHRA), Brignole M, et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace. 2013;15(8):1070–1118. doi: 10.1093/europace/eut206.
10. Clancy RM, Kapur RP, Molad Y, et al. Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage, fibroblast crosstalk in the pathologic cascade leading to congenital heart block. Arthritis Rheum. 2004;50(1):173–182. doi: 10.1002/art.11430.
11. Kosheleva NM, Alekberova ZS. Neonatal lupus. Modern Rheumatology Journal. 2015;9(4):92–97. (In Russ). doi: 10.14412/1996-7012-2015-4-92-97.
12. Bader RS, Hornberger LK, Huhta JC. The perinatal cardiology handbook. 1st ed. Mosby; 2008. 526 p.
13. Zeigler VL, Gillette PG, editors. Practical management of pediatric cardiac arrhythmias. Hoboken, NJ, USA: Wiley-Blackwell; 2001. 416 p.
14. Brucato A, Jonson A, Friedmen D, et al. Proposal for a new definition of congenital complete atrioventricular block. Lupus. 2003;12(6):427–435. doi: 10.1191/0961203303lu408oa.
15. Campbell RM, Douglas PS, Eidem BW, et al. ACC/AAP/ AHA/ASE/HRS/SCAI/SCCT/SCMR/SOPE 2014 appropriate use criteria for initial transthoracic echocardiography in outpatient pediatric cardiology: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Academy of Pediatrics, American Heart Association, American Society of Echocardiography, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Pediatric Echocardiography. J Am Coll Cardiol. 2014;64(19):2039–2060. doi: 10.1016/j.jacc.2014.08.003.
16. Rychik J, Ayres N, Cuneo B, et al. American society of echocardiography guidelines and standards for performance of fetal echocardiography. J Am Soc Echocardiogr. 2004;17(7):803–810. doi: 10.1016/j.echo.2004.04.011.
17. Ostensen M, Khamashta M, Lockshin M, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther. 2006;8(3):209. doi: 10.1186/ar1957.
18. Ruffatti A, Milanesi O, Chiandetti L, et al. A combination therapy to treat second-degree anti-Ro/La-related congenital heart block: a strategy to avoid stable third-degree heart block? Lupus. 2012;21(6):666–671. doi: 10.1177/0961203311430969.
19. Saxena A, Izmirly PM, Mendez B, et al. Prevention and treatment in utero of autoimmune associated congenital heart block. Cardiol Rev. 2014;22(6):263–267. doi: 10.1097/CRD.0000000000000026.
20. Pelliccia A, Fagard R, Bjørnstad HH, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2005;26(14):1422–1445. doi: 10.1093/eurheartj/ehi325.
21. Zipes DP, Link MS, Ackerman MJ, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 9: arrhythmias and conduction defects: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015;66(21):2412–2423. doi: 10.1016/j.jacc.2015.09.041
Review
For citations:
Kovalev I.A., Belozerov Yu.M., Sadykova D.I., Sabirova D.R., Yakovleva L.V., Khabibrakhmanova Z.R., Sakerin A.S. Atrioventricular Block in Children. Pediatric pharmacology. 2018;15(5):365-375. (In Russ.) https://doi.org/10.15690/pf.v15i5.1959
Views:
924
Email this article 